758 related articles for article (PubMed ID: 26234762)
1. Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II-infused rats.
Minas JN; Thorwald MA; Conte D; Vázquez-Medina JP; Nishiyama A; Ortiz RM
Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1178-88. PubMed ID: 26234762
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: the possible role of local renin-angiotensin system.
Hirono Y; Yoshimoto T; Suzuki N; Sugiyama T; Sakurada M; Takai S; Kobayashi N; Shichiri M; Hirata Y
Endocrinology; 2007 Apr; 148(4):1688-96. PubMed ID: 17218415
[TBL] [Abstract][Full Text] [Related]
3. Central mineralocorticoid receptors and the role of angiotensin II and glutamate in the paraventricular nucleus of rats with angiotensin II-induced hypertension.
Gabor A; Leenen FH
Hypertension; 2013 May; 61(5):1083-90. PubMed ID: 23509081
[TBL] [Abstract][Full Text] [Related]
4. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
[TBL] [Abstract][Full Text] [Related]
5. Role of mineralocorticoid receptor on experimental cerebral aneurysms in rats.
Tada Y; Kitazato KT; Tamura T; Yagi K; Shimada K; Kinouchi T; Satomi J; Nagahiro S
Hypertension; 2009 Sep; 54(3):552-7. PubMed ID: 19620512
[TBL] [Abstract][Full Text] [Related]
6. Role of brain corticosterone and aldosterone in central angiotensin II-induced hypertension.
Huang BS; White RA; Ahmad M; Leenen FH
Hypertension; 2013 Sep; 62(3):564-71. PubMed ID: 23856493
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin type 1 receptor mediates chronic ethanol consumption-induced hypertension and vascular oxidative stress.
Passaglia P; Ceron CS; Mecawi AS; Antunes-Rodrigues J; Coelho EB; Tirapelli CR
Vascul Pharmacol; 2015 Nov; 74():49-59. PubMed ID: 25872164
[TBL] [Abstract][Full Text] [Related]
8. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
Stas S; Whaley-Connell A; Habibi J; Appesh L; Hayden MR; Karuparthi PR; Qazi M; Morris EM; Cooper SA; Link CD; Stump C; Hay M; Ferrario C; Sowers JR
Endocrinology; 2007 Aug; 148(8):3773-80. PubMed ID: 17494996
[TBL] [Abstract][Full Text] [Related]
9. Oxidative DNA damage in kidneys and heart of hypertensive mice is prevented by blocking angiotensin II and aldosterone receptors.
Brand S; Amann K; Mandel P; Zimnol A; Schupp N
PLoS One; 2014; 9(12):e115715. PubMed ID: 25551569
[TBL] [Abstract][Full Text] [Related]
10. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.
Keidar S; Kaplan M; Pavlotzky E; Coleman R; Hayek T; Hamoud S; Aviram M
Circulation; 2004 May; 109(18):2213-20. PubMed ID: 15123520
[TBL] [Abstract][Full Text] [Related]
12. Losartan and angiotensin II inhibit aldosterone production in anephric rats via different actions on the intraadrenal renin-angiotensin system.
Peters J; Obermüller N; Woyth A; Peters B; Maser-Gluth C; Kränzlin B; Gretz N
Endocrinology; 1999 Feb; 140(2):675-82. PubMed ID: 9927293
[TBL] [Abstract][Full Text] [Related]
13. Central and peripheral slow-pressor mechanisms contributing to Angiotensin II-salt hypertension in rats.
Lu J; Wang HW; Ahmad M; Keshtkar-Jahromi M; Blaustein MP; Hamlyn JM; Leenen FHH
Cardiovasc Res; 2018 Feb; 114(2):233-246. PubMed ID: 29126194
[TBL] [Abstract][Full Text] [Related]
14. Dual blockade of aldosterone and angiotensin II additively suppresses TGF-beta and NADPH oxidase in the hypertensive kidney.
Onozato ML; Tojo A; Kobayashi N; Goto A; Matsuoka H; Fujita T
Nephrol Dial Transplant; 2007 May; 22(5):1314-22. PubMed ID: 17324946
[TBL] [Abstract][Full Text] [Related]
15. Role of Angiotensin II type 1 receptor on renal NAD(P)H oxidase, oxidative stress and inflammation in nitric oxide inhibition induced-hypertension.
Rincón J; Correia D; Arcaya JL; Finol E; Fernández A; Pérez M; Yaguas K; Talavera E; Chávez M; Summer R; Romero F
Life Sci; 2015 Mar; 124():81-90. PubMed ID: 25623850
[TBL] [Abstract][Full Text] [Related]
16. Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury.
Luther JM; Luo P; Wang Z; Cohen SE; Kim HS; Fogo AB; Brown NJ
Kidney Int; 2012 Sep; 82(6):643-51. PubMed ID: 22622494
[TBL] [Abstract][Full Text] [Related]
17. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
Nagata K; Obata K; Xu J; Ichihara S; Noda A; Kimata H; Kato T; Izawa H; Murohara T; Yokota M
Hypertension; 2006 Apr; 47(4):656-64. PubMed ID: 16505208
[TBL] [Abstract][Full Text] [Related]
18. Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart.
Rocha R; Martin-Berger CL; Yang P; Scherrer R; Delyani J; McMahon E
Endocrinology; 2002 Dec; 143(12):4828-36. PubMed ID: 12446610
[TBL] [Abstract][Full Text] [Related]
19. Cooperative Role of Mineralocorticoid Receptor and Caveolin-1 in Regulating the Vascular Response to Low Nitric Oxide-High Angiotensin II-Induced Cardiovascular Injury.
Pojoga LH; Yao TM; Opsasnick LA; Siddiqui WT; Reslan OM; Adler GK; Williams GH; Khalil RA
J Pharmacol Exp Ther; 2015 Oct; 355(1):32-47. PubMed ID: 26183312
[TBL] [Abstract][Full Text] [Related]
20. Spironolactone improves angiotensin-induced vascular changes and oxidative stress.
Virdis A; Neves MF; Amiri F; Viel E; Touyz RM; Schiffrin EL
Hypertension; 2002 Oct; 40(4):504-10. PubMed ID: 12364354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
